ANI Pharmaceuticals Inc
NASDAQ:ANIP
Wall Street
Price Targets
ANIP Price Targets Summary
ANI Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ANIP is 81.4 USD with a low forecast of 77.77 USD and a high forecast of 87.15 USD.
Operating Income
Forecast
Operating Income Estimate
ANI Pharmaceuticals Inc
For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's operating income is 5%. The projected CAGR for the next 3 years is 53%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ANIP's stock price target?
Price Target
81.4
USD
According to Wall Street analysts, the average 1-year price target for ANIP is 81.4 USD with a low forecast of 77.77 USD and a high forecast of 87.15 USD.
What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
9%
For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 26%. The projected CAGR for the next 3 years is 9%.
What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
53%
For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's operating income is 5%. The projected CAGR for the next 3 years is 53%.
What is ANI Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
98%
For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's net income is 0%. The projected CAGR for the next 3 years is 98%.